Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|HER2-negative Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: 18F-DCFPyL
Sponsor: University of Wisconsin, Madison